Sort
48,018 grants matching “immunotherapy”
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$394,575Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
Mechanisms of Vaccinia Virus Innate Immune Inhibition
$394,547William Lawrence Marshall · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · AI
Il-27-mediated immunoregulation in HSV-1 induced stromal keratitis
$394,545Amol Suryawanshi · North Carolina State University Raleigh · R01 · FY2024 · EY
LAT1 as a Novel Therapeutic Target in Colorectal Cancer
$394,532Subbaya Subramanian · University Of Minnesota · R21 · FY2025 · CA
Optimizing CAR T Cell Therapy
$394,517Bruce R. Blazar · University Of Minnesota · P01 · FY2015 · CA
Phase II Trial of Arimoclomol in IBM
$394,501Mazen Dimachkie · University Of Kansas Medical Center · R01 · FY2015 · FD
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$394,429Michael Lim · Stanford University · R01 · FY2025 · NS
Optimizing Induction Conditions for Immunotherapeutic CTL
$394,429Carol A Kruse · University Of California Los Angeles · R01 · FY2011 · CA
Optimizing Induction Conditions for Immunotherapeutic CTL
$394,429Carol A Kruse · University Of California Los Angeles · R01 · FY2012 · CA
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER
$394,366Robert David Schreiber · Washington University · T32 · FY2022 · CA
Spatial and Temporal Progression of Amyloid Angiopathy
$394,323Matthew P Frosch · Massachusetts General Hospital · R01 · FY2007 · AG
Impact of Chemo-Immunotherapy in Relapsed/Refactory B-CLL
$394,311Neil E Kay · Mayo Clinic Rochester · R01 · FY2006 · CA
Promoting scientific and workforce diversity by enriching the Arkansas Rural Community Health Study (ARCH) among Mother-Daughter Pairs
$394,309Ping-Ching Hsu · Univ Of Arkansas For Med Scis · U24 · FY2025 · ES
Engineering Nanomaterials to Prime Immunity
$394,303James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Structural biophysics and molecular design in cellular immunity
$394,284Brian M Baker · University Of Notre Dame · R35 · FY2019 · GM
Structural biophysics and molecular design in cellular immunity
$394,284Brian M Baker · University Of Notre Dame · R35 · FY2018 · GM
Structural biophysics and molecular design in cellular immunity
$394,284Brian M Baker · University Of Notre Dame · R35 · FY2020 · GM
Structural biophysics and molecular design in cellular immunity
$394,284Brian M Baker · University Of Notre Dame · R35 · FY2017 · GM
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$394,269Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2023 · CA
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$394,269Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$394,269Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2020 · CA
Machine Learning for Integrative Modeling of the Immune System in Clinical Settings
$394,250Nima Aghaeepour · Stanford University · R35 · FY2021 · GM
Machine Learning for Integrative Modeling of the Immune System in Clinical Settings
$394,250Nima Aghaeepour · Stanford University · R35 · FY2023 · GM
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2016 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2017 · CA